Last updated 2026-06-18
- Raised funding round led by The Trendlines Group, Nov 2022
Total raised
—
Last: 2022-11
Stage
Seed
Founded
2022
Headcount
2
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
BeCapio aims to allowing people, dealing with Fecal Incontinence Disorder, to regain control and maintain everyday activities by providing a discrete, noninvasive, multi-modal therapy.
Funding history · 1 round · — total
2022-11
Q&A
- What is BeCapio's primary focus?
- BeCapio aims to provide a discrete, noninvasive, multi-modal therapy for individuals dealing with Fecal Incontinence Disorder, helping them regain control and maintain everyday activities.
- When was BeCapio founded?
- BeCapio was founded in September 2022.
- Who are the lead investors in BeCapio's funding rounds?
- The Trendlines Group and Israel Innovation Authority are among the investors in BeCapio's funding rounds.
- What is BeCapio's primary sector?
- BeCapio's primary sector is Health Tech & Life Sciences.
- Who is the Co-founder and CEO of BeCapio?
- Gil Senesh is the Co-founder and CEO of BeCapio.
- What is the product stage of BeCapio?
- BeCapio's product is currently in the R&D stage.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2C
Tags
therapeuticsnon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2022-9 |
|---|---|
| Employees (exact) | 2 |
Radar intelligence
Patents
| EPO | 2 |
|---|